These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 6136647)
21. Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy. De Bellis A; Sansone D; Coronella C; Conte M; Iorio S; Perrino S; Battaglia M; Bellastella G; Wall JR; Bellastella A; Bizzarro A Clin Endocrinol (Oxf); 2005 Jan; 62(1):24-9. PubMed ID: 15638866 [TBL] [Abstract][Full Text] [Related]
22. Measurement of autoantibodies against human eye muscle plasma membranes in Graves' ophthalmopathy. Faryna M; Nauman J; Gardas A Br Med J (Clin Res Ed); 1985 Jan; 290(6463):191-2. PubMed ID: 3917747 [TBL] [Abstract][Full Text] [Related]
25. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease. Ishikawa N; Eguchi K; Otsubo T; Ueki Y; Fukuda T; Tezuka H; Matsunaga M; Kawabe Y; Shimomura C; Izumi M J Clin Endocrinol Metab; 1987 Jul; 65(1):17-23. PubMed ID: 2953751 [TBL] [Abstract][Full Text] [Related]
26. [A clinical analysis of Graves' ophthalmopathy and ophthalmic Graves' disease]. Liao ZQ Zhonghua Yan Ke Za Zhi; 1992 Jul; 28(4):236-9. PubMed ID: 1299571 [TBL] [Abstract][Full Text] [Related]
27. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay. Ahmann A; Baker JR; Weetman AP; Wartofsky L; Nutman TB; Burman KD J Clin Endocrinol Metab; 1987 Mar; 64(3):454-60. PubMed ID: 2434519 [TBL] [Abstract][Full Text] [Related]
28. Treatment of malignant Graves' ophthalmopathy with cyclosporin-A--a case report. Bakó G; Forizs E; Herczeg L; Kolozsvari L; Leövey A Radiobiol Radiother (Berl); 1987; 28(5):574-6. PubMed ID: 3441606 [No Abstract] [Full Text] [Related]
29. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy. Konuk O; Atasever T; Unal M; Ayvaz G; Yetkin I; Cakir N; Arslan M; Hasanreisoglu B Thyroid; 2002 Jul; 12(7):603-8. PubMed ID: 12193305 [TBL] [Abstract][Full Text] [Related]
30. Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. Mullin BR; Levinson RE; Friedman A; Henson DE; Winand RJ; Kohn LD Endocrinology; 1977 Feb; 100(2):351-66. PubMed ID: 401730 [TBL] [Abstract][Full Text] [Related]
32. Surgical correction of exophthalmos secondary to Graves' disease. Thaller SR; Kawamoto HK Plast Reconstr Surg; 1990 Sep; 86(3):411-8; discussion 419-21. PubMed ID: 2385658 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of B-cell, T-helper-cell, and T-suppressor-cell function in patients with Graves' disease before and after treatment with anti-thyroid drugs. Jones BM; Teng CS; Yeung RT Clin Immunol Immunopathol; 1982 Nov; 25(2):232-42. PubMed ID: 6219845 [No Abstract] [Full Text] [Related]
36. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism. Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764 [TBL] [Abstract][Full Text] [Related]
37. The use of real-time orbital ultrasound in Graves' ophthalmopathy: a comparison with computed tomography. Given-Wilson R; Pope RM; Michell MJ; Cannon R; McGregor AM Br J Radiol; 1989 Aug; 62(740):705-9. PubMed ID: 2670033 [TBL] [Abstract][Full Text] [Related]
38. Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study. Kahaly G; Schrezenmeir J; Krause U; Schweikert B; Meuer S; Muller W; Dennebaum R; Beyer J Eur J Clin Invest; 1986 Oct; 16(5):415-22. PubMed ID: 3100309 [TBL] [Abstract][Full Text] [Related]
39. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease. Goh SY; Ho SC; Seah LL; Fong KS; Khoo DH Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563 [TBL] [Abstract][Full Text] [Related]
40. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid diseases. Wu YJ; Clarke EM; Shepherd P Thyroid; 1998 Feb; 8(2):167-74. PubMed ID: 9510126 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]